Tissue penetration of antimicrobials: Difference between revisions

From IDWiki
Line 305: Line 305:
 
**Posterior includes vitreous humour, retina, and choroid, and is best accessed using intravitreal or systemic medications
 
**Posterior includes vitreous humour, retina, and choroid, and is best accessed using intravitreal or systemic medications
 
*Penetration of systemic antimicrobials into retina and vitreous is poor (~0 to 2%), but is better with inflammation[[CiteRef::brockhaus2019re]]
 
*Penetration of systemic antimicrobials into retina and vitreous is poor (~0 to 2%), but is better with inflammation[[CiteRef::brockhaus2019re]]
  +
**Preferred agents for vitreal penetration include [[meropenem]], [[linezolid]], and [[moxifloxacin]]
βˆ’
*In general, linezolid, ceftazidime, meropenem, and moxifloxacin appear to reliably reach adequate intravitreal levels to be used routinely, and likely vancomycin as well
 
  +
**Agents that are likely effective, especially when inflammation is present, include [[vancomycin]], [[cefazolin]], [[ceftriaxone]], [[ceftazidime]], [[imipenem]], and [[trimethoprim-sulfamethoxazole]], and possible [[daptomycin]] and [[rifampin]]
  +
**Agents that do not reach adequate levels include [[ciprofloxacin]], [[levofloxacin]], [[aminoglycosides]], [[aminopenicillins]], [[piperacillin]], [[cefepime]], and [[clarithromycin]]
   
 
{| class="wikitable"
 
{| class="wikitable"

Revision as of 11:20, 6 March 2021

Summary

Class Antimicrobial Blood CNS Vitreous Urine Prostate Necrotic
Antibiotics: Ξ²-Lactams
Penicillins Ξ²-lactamase inhibitors –
ampicillin + –
piperacillin-tazobactam +†
Cephalosporins first-generation cephalosporins – –
second-generation cephalosporins –
third-generation cephalosporins +†
cefepime +
ceftazidime + +
Cephamycins cephamycins –
cefoxitin –
Carbapenems imipenem +
Antibiotics: Non-Ξ²-Lactams
Aminoglycosides –
Chloramphenicol chloramphenicol +
Fluoroquinolones –? + +
Fosfomycin fosfomycin +
Lincosamides clindamycin – +
Lipopeptides daptomycin + – +
Macrolides macrolides – +
Nitrofurans nitrofurantoin – – + – –
Nitroimidazoles metronidazole +
Rifamycins rifampin +
Sulfonamides trimethoprim-sulfamethoxazole +
Tetracyclines tetracyclines – +
doxycycline + +
Antivirals
acyclovir / valacyclovir +
ganciclovir +
foscarnet
Antifungals
Azoles fluconazole +
Echinocandins + –
Class Antimicrobial Blood CNS Urine Prostate Necrotic
  • † if inflammation present

Specific Tissues

Prostate

  • Poorly penetrated by most antibiotics
  • Penetration is higher with a high concentration gradient, high lipid solubility, low degree of ionization, high dissociation constant, low protein binding, and small molecular size
  • Fluoroquinolones are the mainstay of therapy, though there is increasing resistance
  • TMP-SMX often used, though conflicting data about its penetration into the prostate
  • Minocycline, doxycycline, and macrolides achieve high levels in the prostate but are rarely indicated for the causative organisms
  • Third-generation cephalosporins and carbapenems can be used
  • Piperacillin, aztreonam, imipenem, and some aminoglycosides are likely useful

Bone

  • Essentially all antibiotics achieve similar bone-to-serum levels, with the exception of oral Ξ²-lactams which nevertheless have no worse outcomes1

Eye

Class Antimicrobial Vitreal Penetration
penicillins ampicillin below MIC in non-inflamed rabbit eyes
amoxicillin 2% (below MIC) in non-inflamed rabbit eyes
piperacillin undetectable in inflamed human eyes
cephalosporins cefazolin above MIC in inflamed rabbit eyes
ceftriaxone 4% in non-inflamed human eyes
ceftazidime 30% in inflamed rabbit eyes
cefipime 8% in non-inflamed human eyes
carbapenems imipenem 8 to 10% in non-inflamed human eyes
meropenem 30% in non-inflamed human eyes
oxazolidinones linezolid 30 to 80% in non-inflamed human eyes
vancomycin above MIC in inflamed rabbit eyes
daptomycin 30% in inflamed human eyes
aminoglycosides amikacin below MIC in inflamed rabbit eyes
gentamicin below MIC in inflamed rabbit eyes
fluoroquinolones ciprofloxacin below MIC in non-inflamed human eyes
levofloxacin 30% but below MIC in non-inflamed human eyes
moxifloxacin 10 to 40% and above MIC in non-inflamed human eyes

References

  1. ^  Cornelia B. Landersdorfer, JΓΌrgen B. Bulitta, Martina Kinzig, Ulrike Holzgrabe, Fritz SΓΆrgel. Penetration of Antibacterials into Bone. Clinical Pharmacokinetics. 2009;48(2):89-124. doi:10.2165/00003088-200948020-00002.
  2. ^  L. Brockhaus, D. Goldblum, L. Eggenschwiler, S. Zimmerli, C. Marzolini. Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics. Clinical Microbiology and Infection. 2019;25(11):1364-1369. doi:10.1016/j.cmi.2019.01.017.